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Abstract 
The purpose of our study was to evaluate the impact of diet and dosed physical exercises on clinical and 
laboratory parameters of initial renal dysfunction in patients with abdominal obesity with or without 
arterial hypertension (AH).  
Materials and methods. The effectiveness of diet and physical activity was studied in 46 patients with 
abdominal obesity and initial manifestations of renal damage with or without arterial hypertension. The 
first group’s data are shown below. The average age of patients with abdominal obesity without arterial 
hypertension was 24,0±1,4 years, men were 14 (45.2%), women - 17 (54.8%). Average BMI was equal 
33.1 [31.0; 37.4] kg / m2. The group consisted of patients with abdominal obesity without hypertension 
who were assigned diet and dosed exercises. This group included patients with or without disturbances of 
carbohydrate and lipid metabolism, able of accomplishing exercise and diet. The second group’s data are 
shown below. The average age of patients with abdominal obesity and arterial hypertension 1 degree was 
33,0±1,6 years; men were 5 (33.3%), women - 10 (66.7%). Blood pressure (BP) was between 140-152 / 
86-96 mm Hg, average BMI - 32.1 [31.0; 33.8] kg / m2. Diet and exercises were assigned similar to the 
first group. All patients adhered recommendations. In addition to using general methods of clinical 
research conducted anthropometry, electrocardiography, ultrasound of the kidneys, determination of GFR 
using 24-hour urine collection without adjustment for body surface area, immunoreactive insulin, 
carbohydrate and lipid metabolism, level of leptin in plasma; urine albumin, urine protein, urine β2-
microglobulin, HOMA-IR, urine albumin/urine creatinine ratio, urine protein/urine creatinine ratio, urine 
β2-microglobulin/urine creatinine ratio.  
Results. Significant reduction (p<0.001) of body weight from 97.0 [87.5, 106.0] to 92.0 [84.0, 100.0] kg, 
BMI from 33.1 [31.0; 37.4] to 31.2 [29.7, 35.9] kg / m2 and other anthropometric parameters were 
observed in 100% of cases in the first group under the influence of diet and physical activity. The levels 
of SBP and DBP were within normal limits and did not change significantly. Weight loss of 5.0 kg led to 
a significant decrease (p<0.01) in GFR an average of 1.9 mL / min, β2-mg - 0.6 mg / 24 h. and urine β2-
mg / urine Kr ratio - 0.4 mg / g. Leptin levels significantly (p<0.01) reduced in this group of patients. 
Carbohydrate and lipid metabolism improved in parallel with the decrease in body weight. Level of total 
cholesterol decreased from 5.3 [4.5, 6.1] to 4.9 [4.2, 5.8] mmol / L, LDL - from 3.4 [2.9, 4.5] to 3.2 [2.5, 
4.1] mmol / L, fasting insulin levels - from 31.0 [27.7, 38.6] to 29.1 [22.3, 39.4] mcMO / ml, index 
HOMA-IR - 7.2 [5.9, 10.2] to 6.5 [4.7, 9.1], fasting glucose level - from 5.2 [4.6, 6, 2] to 5.1 [4.5, 5.9] 
mmol / L, glucose after carbohydrate test - from 6.9 [5.6, 7.5] to 6.5 [5.5, 7.5] mmol / L. Diet and dosed 
exercises did not affect for TG, HDL and AI. Diet and dosed exercises have no contraindications, except 
for changes in the general food and mode of motor activity. In the second group weight loss and waist 
circumference were observed in 100% of cases, influenced by diet and physical activity. BMI 
significantly reduced from 32.1 [31.0; 33.8] to 31.6 [29.7; 32.5] kg / m2, waist circumference decreased 
from 102.0 [96.0; 115.0] to 95 [92.0, 112.0] cm, weight - from 95.0 [83.0; 106.0] to 90.0 [80.0; 100.0] kg 
under the influence of diet and physical activity. Consequently, the dynamics of body mass and waist 
circumference in this group was similar group 1. There were no probable modifications of waist/hip ratio 
during the treatment. Normalization of blood pressure after 6 months of treatment was achieved in 8 
(53.3%) patients and a significant decrease in blood pressure - in 4 (26.7%) patients. In 3 (20.0%) 
patients blood pressure didn’t change. GFR normalized in 2 (13.3%) persons, decreased - in 13 (86.7%) 
patients after treatment. The level of β2-mg decreased in 13 (86.7%) patients, did not change - in 2 
(13.3%) patients. Similar changes found in the analysis of β2-mg / Kr urine ratio: normalization of the 
ratio - in 1 (6.7%) patients, reduction of this parameter - in 10 (66.7%) patients, this ratio has not changed 
- in 4 (26, 6%) patients. There were significant improvement in carbohydrate metabolism and HOMA-IR, 
lowering leptin levels in this group of patients. In parallel with weight loss fasting insulin levels 
decreased from 28.6 [24.2; 32.6] to 26.5 [22.1; 32.1] mcMO / ml (p <0.01), decreased initially elevated 
HOMA-IR indexes from 6.2 [4.7, 8.2] to 5.5 [4.4, 7.4] (p <0.01), decreased elevated levels of fasting 
glucose from 4 8 [4.4; 5.6] to 4.5 [4.1, 5.5] mmol / L (p <0.01), decreased elevated glucose levels after 
carbohydrate loading from 5.8 [5 6; 7.6] to 5.6 [5.5, 7.6] mg / dL (p <0.05) and leptin levels from 33.7 
[25.6; 53.1] to 32.0 [22.4; 46.8] ng / ml (p <0.01) in patients with abdominal obesity and hypertension. 
Similar changes observed in the analysis of lipid abnormalities: decreased total cholesterol from 4.9 [4.2, 
5.5] to 4.6 [4.0, 5.2] mmol / L (p <0.01) and LDL from 3.4 [2.3, 3.8] to 3.0 [2.2, 3.4] mmol / L (p <0.01).
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During the treatment there was no probable (p<0,05) modifications 
TG, HDL-C and IA. Reducing averages HOMA-IR for 0.7 and 
weight for 5.0 kg led to a reduction in SBP average for 4 mm Hg and 
DBP for 2 mm Hg, GFR for 10.2 ml / min, β2-mg - 0.1 mg / 24 h. and 
β2-mg / cr urine ratio - 0.1 mg / g. Dynamics of anthropometric 
parameters, leptin levels, insulin resistance, carbohydrate and lipid 
metabolism showed positive changes of kidney function similar group 
№1 in patients with abdominal obesity and hypertension against the 
background of diet and dosed physical activity. Our results confirmed 
the literature. According to literature data weight loss improves renal 
function with a reduction in proteinuria, glomerular hyperfiltration 
and inflammation, and improves control blood glucose levels in 
people with or without obvious renal failure.  
Conclusions. The necessity diet and physical activity was 
substantiated in patients with abdominal obesity and renal 
dysfunction depending on the degree of obesity, metabolic 
characteristics, levels of IR. Diet and physical activity in patients with 
abdominal obesity and early renal damage are an effective way of 
prevention or correction renal dysfunction and associated metabolic 
changes. The research laboratory parameters of kidney function in 
patients with abdominal obesity and renal dysfunction have great 
importance for the diagnostic assessment of the impact diet and 
physical activity on the development and progression of early stages 
of renal damage. 
 
Key words: abdominal obesity, renal dysfunction, diet, physical 
activity. 
 
1. Introductions 
The basic principle of a comprehensive treatment program is 
the prevalence of abdominal obesity energy consumption of 
the energy value of food. The modern treatment concept of 
obesity based on tactics of gradual weight loss - 0.5-1 kg / 
week, stabilization and maintenance of achieved body weight 
with a mandatory reduction the impact of risk factors for 
complications and improve the quality of life. Current 
guidelines complied by WHO, National Institutes of Health 
and the North American Association for the Study of Obesity 
recommend a comprehensive program includes body weight 
control, based on nonmedical methods. It is sustainable 
hypocaloric food based on individual dietary habits, lifestyle, 
age, increasing physical activity for background correction 
stereotypes feeding behavior, the formation of healthy 
lifestyles. According to the literature the physician‘s 
recommendations relative to healthy lifestyles and prevention 
of cardiovascular diseases receive only 10% of patients. 
Weight loss in patients with chronic kidney disease (CKD) is a 
matter not only and not so much the weight loss, but also 
reduce elevated levels of insulin resistance (IR). Despite 
irrational nutrition, especially consumption of large amounts 
of saturated fats and carbohydrates, which plays a decisive role 
in the development of obesity, modified diet usually can’t 
achieve a real reduction of increased body mass and decrease 
associated with it metabolic disorders due to low patient 
adherence. High protein diets, common in the United States 
and Europe, should not be used in patients with impaired renal 
function due to non-enzymatic proteins of glycolysis in renal 
tubules. Recommendations for changes in diet in individuals 
with obesity continues to be based primarily on reducing the 
total number of calories consumed with the number of 
vegetable products. 
Exercise increases energy costs, promote lipolysis, improve 
the function of the cardiovascular system. Lifestyle dosed with 
physical activity and restriction of caloric intake enhances the 
effectiveness of drugs used to treat obesity [1-5]. 
 
2. Object: to evaluate the impact of diet and dosed physical 
exercises on clinical and laboratory parameters of initial renal 
dysfunction in patients with abdominal obesity with or without 
arterial hypertension (AH). 
 
3. Materials and Methods 
The effectiveness of diet and physical activity was studied in 
46 patients with abdominal obesity and initial manifestations 
of renal damage with or without arterial hypertension. 
 Criteria for forming groups: 
1) Abdominal obesity 1-3 degree in anthropometric 
indicators (BMI, waist circumference, waist/hip ratio). 
2) Moderate insulin resistance. 
3) The presence of renal dysfunction’s parameters. 
The first group’s data are shown below. The average age of 
patients with abdominal obesity without arterial hypertension 
was 24,0±1,4 years, men were 14 (45.2%), women - 17 
(54.8%). Average BMI was equal 33.1 [31.0; 37.4] kg / m2. 
The group consisted of patients with abdominal obesity 
without hypertension who were assigned diet and dosed 
exercises. This group included patients with or without 
disturbances of carbohydrate and lipid metabolism, able of 
accomplishing exercise and diet. 
The second group’s data are shown below. The average age of 
patients with abdominal obesity and arterial hypertension 1 
degree was 33,0±1,6 years; men were 5 (33.3%), women - 10 
(66.7%). Blood pressure (BP) was between 140-152/86-96 
mm Hg., average BMI - 32.1 [31.0; 33.8] kg / m2. Diet and 
exercises were assigned similar to the first group. All patients 
adhere recommendations. 
Diet was calculated on the basis of basal energy balance 
(BEB). We used the Harris – Benedict formula: 
Men BEB (kcal) = 66,47 + 13,75W + 5,0 H-6,77 A; 
Women BEB (kcal) = 65,51 + 9,56 W + 1,85 H - 4,67 A, 
where: W = weight (kg), H = height (cm), A = age (years). 
Then the resulting value BEB multiply for 1,3 - ratio of 
exercise. Physical activity offered daily from 20 to 40 minutes 
once or twice a day [4]. 
In addition to using general methods of clinical research 
conducted anthropometry, electrocardiography, ultrasound of 
the kidneys, determination of GFR using 24-hour urine 
collection without adjustment for body surface area, 
immunoreactive insulin, carbohydrate and lipid metabolism, 
level of leptin in plasma; urine albumin, urine protein, urine 
β2-microglobulin, insulin resistance index - HOMA-IR, urine 
albumin / urine creatinine ratio, urine protein / urine creatinine 
ratio, urine β2-microglobulin / urine creatinine ratio. 
Statistical analysis of the research results carried out by 
methods of variation statistics implemented a standard 
application package "Statistica 6.1, Serial AGAR 
909E415822FA" and "Microsoft Excel". Data were presented 
as median (Me) and borders interquartile interval [25%; 75%] 
when describing quantitative signs. Quality signs were defined 
as minimum and maximum for each parameter in absolute 
numbers and percentages. The level of significance was 
considered significant at p<0,05. 
 
4. Results 
In the first group initial data and dynamics of anthropometry 
and blood pressure levels, which changed after the treatment 
represented in Table 1. Significant reduction (p<0.001) of 
body weight from 97.0 [87.5, 106.0] to 92.0 [84.0, 100.0] kg, 
BMI from 33.1 [31.0; 37.4] to 31.2 [29.7, 35.9] kg / m2 and 
other anthropometric parameters were observed in 100% of 
cases under the influence of diet and physical activity. The 
levels of SBP and DBP were within normal limits and did not 
change significantly. 
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Table 1: The dynamics of anthropometry and blood pressure in 
patients with abdominal obesity without hypertension under the 
influence of diet and dosed physical exercises (n = 31) 
 
Parameter Before treatment After treatment 
Body weight, kg 97,0 [87,5;106,0] 92,0 [84,0;100,0]* 
Waist circumference, см 105,0 [98,0;110,0] 
100,0 
[96,0;106,0]* 
Waist/hip circumference 
ratio 0,92 [0,9;1,0] 0,9 [0,87;1,0]* 
BMI, kg / m22 33,1 [31,0;37,4] 31,2 [29,7;35,9]* 
SBP, mmHg 120,0 [118,0;120,0] 
120,0 
[116,0;120,0]# 
DBP, mmHg 70,0 [70,0;80,0] 70,0 [70,0;76,0]# 
Notes: * - p <0.001; # - p> 0,05. 
 
The evaluation of kidney function parameters is shown in 
Table 2. Weight loss of 5.0 kg led to a significant decrease 
(p<0.01) in GFR an average of 1.9 mL / min, β2-mg - 0.6 mg / 
24 h. and urine β2-mg / urine Kr ratio - 0.4 mg / g (tabl.2). 
 
Table 2: The assessment of kidney function in patients with 
abdominal obesity without hypertension under the influence of diet 
and dosed physical exercises (n = 31) 
 
Parameter Before treatment After treatment 
GFR, mL / min 163,0 [142,4;186,7] 
149,2 
[127,3;171,6]* 
β2- mg, mg /24 H. 1,6 [0,8;3,5] 1,5 [0,6;3,2]** 
β2- mg / Kr urine ratio, mg 
/ g 1,6 [0,8;3,5] 1,0 [0,6;2,3]* 
Notes: * - p <0.001; ** - p <0.05. 
 
Leptin levels significantly (p<0.01) reduced in this group of 
patients. Carbohydrate and lipid metabolism improved in 
parallel with the decrease in body weight. According to the 
table 3 level of total cholesterol decreased from 5.3 [4.5, 6.1] 
to 4.9 [4.2, 5.8] mmol / L, LDL - from 3.4 [2.9, 4.5] to 3.2 
[2.5, 4.1] mmol / L, fasting insulin levels - from 31.0 [27.7, 
38.6] to 29.1 [22.3, 39.4] mcMO / ml, index HOMA-IR - 7.2 
[5.9, 10.2] to 6.5 [4.7, 9.1], fasting glucose level - from 5.2 
[4.6, 6, 2] to 5.1 [4.5, 5.9] mmol / L, glucose after 
carbohydrate test - from 6.9 [5.6, 7.5] to 6.5 [5.5, 7.5] mmol / 
L. Diet and dosed exercises did not affect for TG, HDL and 
AI. Diet and dosed exercises have no contraindications, except 
for changes in the general food and mode of motor activity 
(tabl.3). 
 
Table 3: The dynamics of the lipids and carbohydrates metabolism, 
insulin resistance in patients with abdominal obesity without 
hypertension under the influence of diet and dosed exercises 
(n = 31) 
 
Parameter Before  treatment 
After  
treatment 
Fasting glucose, mmol / L 5,2 [4,6;6,2] 5,1 [4,5;5,9]** 
Glucose after carbohydrate 
test, mmol / L 6,9 [5,6;7,5] 6,5 [5,5;7,5]* 
Insulin, mcMO / ml 31,0 [27,7;38,6] 29,1 [22,3;39,4]* 
HOMA-IR 7,2 [5,9;10,2] 6,5 [4,7;9,1]* 
Total cholesterol, mmol / L 5,3 [4,5;6,1] 4,9 [4,2;5,8]* 
TG, mmol / L 1,2 [0,8;1,8] 1,1 [0,8;1,7]# 
HDL, mmol / L 1,2 [1,1;1,3] 1,2 [1,1;1,3]# 
LDL, mmol / L 3,4 [2,9;4,5] 3,2 [2,5;4,1]** 
АI 3,7 [2,7;4,9] 3,1 [2,5;4,0]* 
Leptin, ng / mL 33,7 [25,6;53,1] 32,0 [22,4;46,8]* 
Notes: * -p <0.001; ** - p <0.01; # - p> 0,05. 
In the second group weight loss and waist circumference were 
observed in 100% of cases, influenced by diet and physical 
activity. BMI significantly reduced from 32.1 [31.0; 33.8] to 
31.6 [29.7; 32.5] kg / m2, waist circumference decreased from 
102.0 [96.0; 115.0] to 95 [92.0, 112.0] cm, weight - from 95.0 
[83.0; 106.0] to 90.0 [80.0; 100.0] kg under the influence of 
diet and physical activity. Consequently, the dynamics of body 
mass and waist circumference in this group was similar group 
1. There was no probable modifications of waist/hip ratio 
during the treatment. Normalization of blood pressure after 6 
months of treatment was achieved in 8 (53.3%) patients and a 
significant decrease in blood pressure - in 4 (26.7%) patients. 
In 3 (20.0%) patients blood pressure didn’t change (tabl.4). 
 
Table 4: The dynamics of anthropometry and blood pressure in 
patients with abdominal obesity and hypertension under the influence 
of diet and dosed physical exercises (n = 15) 
 
Parameter Before treatment After treatment 
Body weight, kg 95,0 [83,0;106,0] 90,0 [80,0;100,0]* 
Waist circumference, см 102,0 [96,0;115,0] 95,0 [92,0;112,0]* 
Waist/hip circumference 
ratio 0,91 [0,87;0,95] 0,9 [0,87;0,95]# 
BMI, kg / m22 32,1 [31,0;33,8] 31,6 [29,7;32,5]* 
SBP, mmHg 142,0 [140,0;146,0] 
138,0 
[136,0;144,0]** 
DBP, mmHg 90,0 [90,0;92,0] 88,0 [86,0;88,0]** 
Notes: * - р<0,001; ** - р<0,01; # - p>0,05. 
 
GFR normalized in 2 (13.3%) persons, decreased - in 13 
(86.7%) patients after treatment. The level of β2-mg decreased 
in 13 (86.7%) patients, did not change - in 2 (13.3%) patients. 
Similar changes found in the analysis of β2-mg / Kr urine ratio: 
normalization of the ratio - in 1 (6.7%) patients, reduction of 
this parameter - in 10 (66.7%) patients, this ratio has not 
changed - in 4 (26, 6%) patients (tabl.5). 
 
Table 5: The assessment of kidney function in patients with 
abdominal obesity and hypertension under the influence of diet and 
dosed physical exercises (n = 15) 
 
Parameter Before treatment After treatment 
GFR, mL / min 143,6 [125,6;168,5] 
133,4 
[121,3;147,0]** 
β2- mg, mg /24 H. 0,9 [0,6;1,8] 0,8 [0,5;1,4]* 
β2- mg / Kr urine ratio, 
mg / g 0,7 [0,4;1,4] 0,6 [0,4;1,2]* 
Notes: * - р<0,001; ** - р<0,05. 
 
Research results of lipid and carbohydrate metabolism, 
HOMA-IR, hormones insulin and leptin levels, represented in 
Table 6. There were significant improvement in carbohydrate 
metabolism and HOMA-IR, lowering leptin levels in this 
group of patients. 
In parallel with weight loss fasting insulin levels decreased 
from 28.6 [24.2; 32.6] to 26.5 [22.1; 32.1] mcMO / ml (p 
<0.01), decreased initially elevated HOMA-IR indexes from 
6.2 [4.7, 8.2] to 5.5 [4.4, 7.4] (p <0.01), decreased elevated 
levels of fasting glucose from 4 8 [4.4; 5.6] to 4.5 [4.1, 5.5] 
mmol / L (p <0.01), decreased elevated glucose levels after 
carbohydrate loading from 5.8 [5 6; 7.6] to 5.6 [5.5, 7.6] mg / 
dL (p <0.05) and leptin levels from 33.7 [25.6; 53.1] to 32.0 
[22.4; 46.8] ng / ml (p <0.01) in patients with abdominal 
obesity and hypertension (tabl.6). 
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Table 6: The dynamics of the lipids and carbohydrates metabolism, 
insulin resistance in patients with abdominal obesity and hypertension 
under the influence of diet and dosed exercises 
(n = 15) 
 
Parameter Before treatment 
After  
treatment 
Fasting glucose, mmol / L 4,8[(4,4;5,6] 4,5 [4,1;5,5]* 
Glucose after carbohydrate 
loading, mmol / L 5,8 [5,6;7,6] 5,6 [5,5;7,6]** 
Insulin, mcMO / ml 28,6 [24,2;32,6] 26,5 [22,1;32,1]* 
HOMA-IR 6,2 [4,7;8,2] 5,5 [4,4;7,4]* 
Total cholesterol, mmol / L 4,9 [4,2;5,5] 4,6 [4,0;5,2]* 
TG, mmol / L 0,9 [0,8;1,4] 0,9 [0,8;1,2]# 
HDL, mmol / L 1,2 [1,1;1,3] 1,2 [1,2;1,3]# 
LDL mmol / L 3,4 [2,3;3,8] 3,0 [2,2;3,4]* 
АI 3,3 [2,2;3,6] 2,8 [2,1;3,3]# 
Leptin, ng / mL 33,7 [25,6;53,1] 32,0 [22,4;46,8]* 
Notes: *-р<0,01; ** - р<0,05; #- p>0,05. 
 
Similar changes observed in the analysis of lipid 
abnormalities: decreased total cholesterol from 4.9 [4.2, 5.5] to 
4.6 [4.0, 5.2] mmol / L (p <0.01) and LDL from 3.4 [2.3, 3.8] 
to 3.0 [2.2, 3.4] mmol / L (p <0.01). During the treatment there 
was no probable (p<0,05) modifications TG, HDL-C and IA 
(tabl.6). 
Reducing averages HOMA-IR for 0.7 and weight for 5.0 kg 
led to a reduction in SBP average for 4 mm Hg and DBP for 2 
mm Hg, GFR for 10.2 ml / min, β2-mg - 0.1 mg / 24 h. and 
β2-mg / cr urine ratio - 0.1 mg / g. 
Dynamics of anthropometric parameters, leptin levels, insulin 
resistance, carbohydrate and lipid metabolism showed positive 
changes of kidney function similar group №1 in patients with 
abdominal obesity and hypertension against the background of 
diet and dosed physical activity. 
Our results confirmed the literature. According to literature 
data weight loss improves renal function with a reduction in 
proteinuria, glomerular hyperfiltration and inflammation, and 
improves control blood glucose levels in people with or 
without obvious renal failure. 
 
5. Conclusions 
1. The necessity diet and physical activity was substantiated 
in patients with abdominal obesity and renal dysfunction 
depending on the degree of obesity, metabolic 
characteristics, levels of IR. 
2. Diet and physical activity in patients with abdominal 
obesity and early renal damage are an effective way of 
prevention or correction renal dysfunction and associated 
metabolic changes. 
3. The research laboratory parameters of kidney function in 
patients with abdominal obesity and renal dysfunction 
have great importance for the diagnostic assessment of the 
impact diet and physical activity on the development and 
progression of early stages of renal damage. 
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